Valuation check: VRAY's profit margin is -107.85%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2023
Trailing 12 months ending Mar 2023
ViewRay (VRAY) currently reports a profit margin of -107.85% as of March 2023. That compares with -146.15% in the prior-year period — up 26.2% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore ViewRay's profit margin history and peer comparisons.
ViewRay's profit margin increased from -146.15% to -107.85% — a 26.2% year-over-year increase (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
ViewRay's profit margin of -107.85% is lower than the Healthcare sector average of 13.89%. That is roughly 876.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but ViewRay's current -107.85% should be judged against Healthcare norms (sector average: 13.89%) and against VRAY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -107.85%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for ViewRay, and consider following VRAY for alerts when major investors trade the stock.